Skip to main content
. Author manuscript; available in PMC: 2018 Jun 15.
Published in final edited form as: Oncogene. 2017 Jan 23;36(24):3441–3449. doi: 10.1038/onc.2016.494

Figure 7.

Figure 7

HSP90 knockdown impairs CLL tumor cell viability. (a) Efficiency of HSP90 knockdown was assessed by western blot (N =4). Mock, mock transfection; NT, cells were transfected with a pool of non-targeting siRNA. siHSP, cells were transfected with a pool of siRNA against HSP90. GAPDH, western loading control. (b) Effects of siRNA on CLL cell viability (N =6). ***P<0.001.